Literature DB >> 338904

Conformational analysis of the molecule luteinizing hormone-releasing hormone. 3. Analogue inhibitors and antagonists.

F A Momany.   

Abstract

Conformational energy calculations have been carried out on analogues of luteinizing hormone-releasing hormone which have been shown to be potent inhibitors of the release of luteinizing hormone and follicle-stimulating hormone. The analogues included in this study have D-amino acid substitutions in the 2 and/or 3 positions, such as [D-X2]-LH-RH, [D-X2,D-Y3]-LH-RH, [D-X2,Pro3]-lh-rh, and [D-X2,Leu3]-LH-RH. A configurational property which was common to the low-energy conformers of all the analogues is the directional change of the cis-peptide bond of the pyroglutamate ring. Further, there was no overall structural change in the analogues relative to the conformation of native LH-RH, and the orientation of the aromatic side chains relative to one another remained the same throughout this series of analogues.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 338904     DOI: 10.1021/jm00199a011

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Investigation of the influence of a cyclic luliberin analog on ovulation.

Authors:  V V Korkhov; V P Makusheva; G E Lupanova; S V Burov; S V Nikolaev
Journal:  Neurosci Behav Physiol       Date:  1986 Nov-Dec

2.  The low-energy conformations of gonadotropin-releasing hormone in aqueous solution.

Authors:  Matthew R Pincus; Jannie Woo; Regina Monaco; Jack Lubowsky; Matthew J Avitable; Robert P Carty
Journal:  Protein J       Date:  2014-12       Impact factor: 2.371

Review 3.  A benefit-risk assessment of medical treatment for uterine leiomyomas.

Authors:  Vincenzo De Leo; Giuseppe Morgante; Antonio La Marca; Maria Concetta Musacchio; Massimo Sorace; Chiara Cavicchioli; Felice Petraglia
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.